Ripretinib: A Review in Gastrointestinal Stromal Tumours as Fourth-or Later-Line of Therapy

Fung, S; Shirley, M

Fung, S (通讯作者),Springer Nat, Private Bag 65901, Auckland 0754, New Zealand.

DRUGS, 2022; 82 (15): 1541

Abstract

Ripretinib (Qinlock (R)) is a small molecule inhibitor of the receptor tyrosine kinases KIT and platelet-derived growth factor receptor alpha (PDGFRA)......

Full Text Link